12:00 AM
Mar 25, 2013
 |  BC Week In Review  |  Company News  |  Other News

Sanofi cardiovascular news

Sanofi disclosed in its 2012 earnings that the U.S. Department of Justice is investigating "disclosures to the FDA regarding the variability of response to" cardiovascular drug Plavix clopidogrel....

Read the full 128 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >